Clinical Trials on Refractory Overactive Bladder in Denmark
Total 186 results
-
University of AarhusCompleted
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Neurogenic Detrusor OveractivityDenmark, Poland
-
University of AarhusUniversity Hospital, GhentUnknown
-
University of AarhusCompletedOveractive Bladder | Urinary IncontinenceDenmark
-
University of AarhusCompletedOveractive Bladder | Urinary IncontinenceDenmark
-
Vendsyssel HospitalUniversity of AarhusCompletedRed Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive BladderOveractive Bladder | Urge IncontinenceDenmark
-
Anne Estrup OlesenUniversity College of Northern DenmarkEnrolling by invitationOveractive Bladder | Deprescribing | PIMSDenmark
-
Astellas Pharma IncCompletedOveractive Bladder | Neurogenic Detrusor OveractivityBelgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
-
Herning HospitalNot yet recruitingBreast Cancer | Menopause | Vaginal Atrophy | Endometrial Cancer | Bladder, Overactive | Laser-Induced ScarDenmark
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive Bladder (OAB)United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urgency Incontinence | Urinary Bladder OveractiveCzechia, Denmark, Greece, Ireland, Slovakia, Spain, Sweden, United Kingdom
-
Rigshospitalet, DenmarkCopenhagen Academy for Medical Education and SimulationActive, not recruitingBladder Cancer | Virtual Reality | EducationDenmark
-
Herlev and Gentofte HospitalRegion Hovedstadens ApotekRecruitingOveractive Bladder | Anesthesia, Local | Urinary Tract Infections | Pain, Procedural | Urge Incontinence | HematuriaDenmark
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
-
Aalborg University HospitalAarhus University Hospital; Regional Hospital West Jutland; North Denmark Regional...RecruitingBehavioral Symptoms | Mental Disorders | Urologic Diseases | Lower Urinary Tract Symptoms | Urological Manifestations | Urinary Incontinence | Urination Disorders | Elimination Disorders | Daytime Wetting | Urination InvoluntaryDenmark
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveSweden, United Kingdom, Belgium, Denmark
-
Jørgen Bjerggaard JensenCompleted
-
Rigshospitalet, DenmarkCopenhagen Academy for Medical Education and SimulationCompletedMedical Education | Bladder Cancer | Validity-evidence for a Simulator-based Test | Virtual Simulation | Surgical Skill Training | Transurethral Resection of BladdertumorsDenmark
-
Jørgen Bjerggaard JensenCepheidActive, not recruitingNon-muscle Invasive Bladder Cancer | Urinary BiomarkerDenmark
-
PfizerCompletedOveractive BladderDenmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
PfizerCompletedOveractive BladderKorea, Republic of, United States, Denmark, Germany, Canada, Hungary, Poland, France, United Kingdom, Slovakia, Sweden, Mexico, Czech Republic, Finland, Italy, Lithuania, Argentina, Chile, Colombia, Egypt, Greece, Norway, Philippines, Russian Federation and more
-
InnoCon MedicalOdense University Hospital; Aarhus University Hospital; Herlev HospitalRecruitingUrinary Incontinence | Fecal Incontinence | Urinary Incontinence, Urge | Nocturia | Fecal Incontinence With Fecal Urgency | Urinary Frequency More Than Once at Night | Incontinence, Nighttime Urinary | Bowel Disorders FunctionalDenmark
-
InnoCon MedicalOdense University Hospital; Aarhus University Hospital; Herlev HospitalCompletedUrinary Incontinence | Fecal Incontinence | Urge Incontinence | Urinary Incontinence, Urge | Nocturia | Urinary Frequency More Than Once at Night | Incontinence, Nighttime Urinary | Bowel Disorders FunctionalDenmark
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityUnited States, Belgium, Brazil, Denmark, Hungary, Korea, Republic of, Mexico, Philippines, Poland, Turkey
-
Astellas Pharma Global Development, Inc.RecruitingNeurogenic Detrusor OveractivityPhilippines, Turkey, Belgium, Denmark
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
Jørgen Bjerggaard JensenCompletedRenal Cell Carcinoma | Bladder CancerDenmark
-
University Hospital Bispebjerg and FrederiksbergUnknownBladder CancerDenmark
-
Varian, a Siemens Healthineers CompanyRigshospitalet, Denmark; Herlev HospitalRecruitingMuscle-Invasive Bladder CarcinomaDenmark
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Spain, Belarus, Belgium, Ukraine, Denmark, Greece, Russian Federation, Czech Republic, Netherlands, Germany, Hungary, Italy, Slovakia, Sweden, Norway
-
Copenhagen University Hospital at HerlevUnknown
-
PfizerCompletedUrinary Bladder, OveractivePortugal, Spain, Turkey, Finland, Germany, Norway, Sweden, Slovakia, Italy, Austria, United Kingdom, Belgium, Denmark, Israel, Switzerland
-
Jørgen Bjerggaard JensenUniversity of AarhusRecruitingNon-Muscle Invasive Bladder CancerDenmark
-
Jørgen Bjerggaard JensenRecruiting
-
Aarhus University HospitalRecruiting
-
Herlev HospitalUnknown
-
University Hospital Bispebjerg and FrederiksbergProff Dr Jürgen Popp, Leibniz Institute, IPHT, Jena, Germany; Karin Mogensen... and other collaboratorsRecruitingEndoscopic Bladder Cancer Diagnosis With RamanDenmark
-
University of AarhusOdense University Hospital; Copenhagen University Hospital at HerlevCompletedAdverse Effects for Adaptive RT of Bladder CancerDenmark
-
Gregers G HermannUnknown
-
Jørgen Bjerggaard JensenOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Herlev Hospital and other collaboratorsRecruitingBladder Cancer | Bladder Cancer, MetastaticDenmark
-
University of AarhusAarhus University HospitalCompleted
-
University of AarhusAarhus University HospitalCompleted
-
Rigshospitalet, DenmarkMerck Sharp & Dohme LLC; Roche Pharma AG; Beckett Foundation; Onkologisk ForskningsfondUnknownUrinary Bladder NeoplasmDenmark